GRI Bio increases ATM offering capacity to $2.64M, reports $961K already sold

GRI Bio, Inc.

Maximum aggregate gross proceeds from ATM offering raised to $2,644,609 via prospectus supplement filed July 26, 2024.
Approximately $961,272 of shares have already been sold under the May 20, 2024 Sales Agreement with H.C. Wainwright & Co.
Shares are common stock, par value $0.0001 per share; proceeds used for general corporate purposes.

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.